Go Pro

Senseonics Holdings, Inc. Common Stock (SENS) Competitors

Senseonics Holdings, Inc. Common Stock logo
$9.34 -0.18 (-1.89%)
As of 04:00 PM Eastern

SENS vs. AORT, IART, DRTS, STAA, and PRCT

Should you buy Senseonics Holdings, Inc. Common Stock stock or one of its competitors? Senseonics Holdings, Inc. Common Stock's main competitors and comparable companies include Artivion (AORT), Integra LifeSciences (IART), Alpha Tau Medical (DRTS), STAAR Surgical (STAA), and PROCEPT BioRobotics (PRCT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Senseonics Holdings, Inc. Common Stock compare to Artivion?

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) and Artivion (NYSE:AORT) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, media sentiment, dividends, valuation and earnings.

12.4% of Senseonics Holdings, Inc. Common Stock shares are owned by institutional investors. Comparatively, 86.4% of Artivion shares are owned by institutional investors. 4.7% of Senseonics Holdings, Inc. Common Stock shares are owned by insiders. Comparatively, 6.3% of Artivion shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Artivion had 1 more articles in the media than Senseonics Holdings, Inc. Common Stock. MarketBeat recorded 5 mentions for Artivion and 4 mentions for Senseonics Holdings, Inc. Common Stock. Senseonics Holdings, Inc. Common Stock's average media sentiment score of 1.92 beat Artivion's score of 1.08 indicating that Senseonics Holdings, Inc. Common Stock is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Senseonics Holdings, Inc. Common Stock
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Artivion
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Senseonics Holdings, Inc. Common Stock presently has a consensus target price of $17.20, indicating a potential upside of 84.15%. Artivion has a consensus target price of $44.83, indicating a potential upside of 64.77%. Given Senseonics Holdings, Inc. Common Stock's higher probable upside, analysts clearly believe Senseonics Holdings, Inc. Common Stock is more favorable than Artivion.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Senseonics Holdings, Inc. Common Stock
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50
Artivion
1 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.75

Senseonics Holdings, Inc. Common Stock has a beta of 1.01, meaning that its share price is 1% more volatile than the broader market. Comparatively, Artivion has a beta of 1.25, meaning that its share price is 25% more volatile than the broader market.

Artivion has higher revenue and earnings than Senseonics Holdings, Inc. Common Stock. Artivion is trading at a lower price-to-earnings ratio than Senseonics Holdings, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Senseonics Holdings, Inc. Common Stock$35.26M11.07-$69.11M-$2.23N/A
Artivion$441.33M3.01$9.77M-$0.07N/A

Artivion has a net margin of -0.67% compared to Senseonics Holdings, Inc. Common Stock's net margin of -225.09%. Artivion's return on equity of 6.07% beat Senseonics Holdings, Inc. Common Stock's return on equity.

Company Net Margins Return on Equity Return on Assets
Senseonics Holdings, Inc. Common Stock-225.09% -165.80% -80.14%
Artivion -0.67%6.07%2.93%

Summary

Artivion beats Senseonics Holdings, Inc. Common Stock on 12 of the 16 factors compared between the two stocks.

How does Senseonics Holdings, Inc. Common Stock compare to Integra LifeSciences?

Integra LifeSciences (NASDAQ:IART) and Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk, dividends and media sentiment.

Senseonics Holdings, Inc. Common Stock has lower revenue, but higher earnings than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than Senseonics Holdings, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Integra LifeSciences$1.64B0.80-$516.47M-$0.09N/A
Senseonics Holdings, Inc. Common Stock$35.26M11.07-$69.11M-$2.23N/A

Integra LifeSciences has a net margin of -0.44% compared to Senseonics Holdings, Inc. Common Stock's net margin of -225.09%. Integra LifeSciences' return on equity of 18.30% beat Senseonics Holdings, Inc. Common Stock's return on equity.

Company Net Margins Return on Equity Return on Assets
Integra LifeSciences-0.44% 18.30% 5.30%
Senseonics Holdings, Inc. Common Stock -225.09%-165.80%-80.14%

In the previous week, Integra LifeSciences had 1 more articles in the media than Senseonics Holdings, Inc. Common Stock. MarketBeat recorded 5 mentions for Integra LifeSciences and 4 mentions for Senseonics Holdings, Inc. Common Stock. Senseonics Holdings, Inc. Common Stock's average media sentiment score of 1.92 beat Integra LifeSciences' score of 1.35 indicating that Senseonics Holdings, Inc. Common Stock is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Integra LifeSciences
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Senseonics Holdings, Inc. Common Stock
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

84.8% of Integra LifeSciences shares are held by institutional investors. Comparatively, 12.4% of Senseonics Holdings, Inc. Common Stock shares are held by institutional investors. 3.8% of Integra LifeSciences shares are held by insiders. Comparatively, 4.7% of Senseonics Holdings, Inc. Common Stock shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Integra LifeSciences has a beta of 1.21, meaning that its stock price is 21% more volatile than the broader market. Comparatively, Senseonics Holdings, Inc. Common Stock has a beta of 1.01, meaning that its stock price is 1% more volatile than the broader market.

Integra LifeSciences currently has a consensus target price of $18.86, indicating a potential upside of 11.71%. Senseonics Holdings, Inc. Common Stock has a consensus target price of $17.20, indicating a potential upside of 84.15%. Given Senseonics Holdings, Inc. Common Stock's stronger consensus rating and higher probable upside, analysts plainly believe Senseonics Holdings, Inc. Common Stock is more favorable than Integra LifeSciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integra LifeSciences
2 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.88
Senseonics Holdings, Inc. Common Stock
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

Integra LifeSciences and Senseonics Holdings, Inc. Common Stock tied by winning 8 of the 16 factors compared between the two stocks.

How does Senseonics Holdings, Inc. Common Stock compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTS) and Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings, institutional ownership and media sentiment.

Alpha Tau Medical currently has a consensus price target of $12.80, indicating a potential downside of 14.44%. Senseonics Holdings, Inc. Common Stock has a consensus price target of $17.20, indicating a potential upside of 84.15%. Given Senseonics Holdings, Inc. Common Stock's higher probable upside, analysts clearly believe Senseonics Holdings, Inc. Common Stock is more favorable than Alpha Tau Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Tau Medical
1 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.50
Senseonics Holdings, Inc. Common Stock
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, Alpha Tau Medical had 2 more articles in the media than Senseonics Holdings, Inc. Common Stock. MarketBeat recorded 6 mentions for Alpha Tau Medical and 4 mentions for Senseonics Holdings, Inc. Common Stock. Senseonics Holdings, Inc. Common Stock's average media sentiment score of 1.92 beat Alpha Tau Medical's score of 0.92 indicating that Senseonics Holdings, Inc. Common Stock is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alpha Tau Medical
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Senseonics Holdings, Inc. Common Stock
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

2.7% of Alpha Tau Medical shares are owned by institutional investors. Comparatively, 12.4% of Senseonics Holdings, Inc. Common Stock shares are owned by institutional investors. 39.5% of Alpha Tau Medical shares are owned by insiders. Comparatively, 4.7% of Senseonics Holdings, Inc. Common Stock shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Alpha Tau Medical has higher earnings, but lower revenue than Senseonics Holdings, Inc. Common Stock. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Senseonics Holdings, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/A-$42.63M-$1.04N/A
Senseonics Holdings, Inc. Common Stock$35.26M11.07-$69.11M-$2.23N/A

Alpha Tau Medical has a beta of 1.17, suggesting that its stock price is 17% more volatile than the broader market. Comparatively, Senseonics Holdings, Inc. Common Stock has a beta of 1.01, suggesting that its stock price is 1% more volatile than the broader market.

Alpha Tau Medical has a net margin of 0.00% compared to Senseonics Holdings, Inc. Common Stock's net margin of -225.09%. Alpha Tau Medical's return on equity of -138.12% beat Senseonics Holdings, Inc. Common Stock's return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A -138.12% -81.68%
Senseonics Holdings, Inc. Common Stock -225.09%-165.80%-80.14%

Summary

Alpha Tau Medical beats Senseonics Holdings, Inc. Common Stock on 8 of the 14 factors compared between the two stocks.

How does Senseonics Holdings, Inc. Common Stock compare to STAAR Surgical?

STAAR Surgical (NASDAQ:STAA) and Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, media sentiment, profitability, institutional ownership, earnings, valuation and dividends.

96.7% of STAAR Surgical shares are owned by institutional investors. Comparatively, 12.4% of Senseonics Holdings, Inc. Common Stock shares are owned by institutional investors. 39.9% of STAAR Surgical shares are owned by company insiders. Comparatively, 4.7% of Senseonics Holdings, Inc. Common Stock shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Senseonics Holdings, Inc. Common Stock has lower revenue, but higher earnings than STAAR Surgical. Senseonics Holdings, Inc. Common Stock is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
STAAR Surgical$239.44M4.79-$80.45M$0.07326.57
Senseonics Holdings, Inc. Common Stock$35.26M11.07-$69.11M-$2.23N/A

STAAR Surgical presently has a consensus target price of $28.40, indicating a potential upside of 24.23%. Senseonics Holdings, Inc. Common Stock has a consensus target price of $17.20, indicating a potential upside of 84.15%. Given Senseonics Holdings, Inc. Common Stock's stronger consensus rating and higher possible upside, analysts plainly believe Senseonics Holdings, Inc. Common Stock is more favorable than STAAR Surgical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
STAAR Surgical
3 Sell rating(s)
7 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.08
Senseonics Holdings, Inc. Common Stock
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

STAAR Surgical has a net margin of 1.13% compared to Senseonics Holdings, Inc. Common Stock's net margin of -225.09%. STAAR Surgical's return on equity of 9.05% beat Senseonics Holdings, Inc. Common Stock's return on equity.

Company Net Margins Return on Equity Return on Assets
STAAR Surgical1.13% 9.05% 6.99%
Senseonics Holdings, Inc. Common Stock -225.09%-165.80%-80.14%

In the previous week, Senseonics Holdings, Inc. Common Stock had 2 more articles in the media than STAAR Surgical. MarketBeat recorded 4 mentions for Senseonics Holdings, Inc. Common Stock and 2 mentions for STAAR Surgical. Senseonics Holdings, Inc. Common Stock's average media sentiment score of 1.92 beat STAAR Surgical's score of 0.38 indicating that Senseonics Holdings, Inc. Common Stock is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
STAAR Surgical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Senseonics Holdings, Inc. Common Stock
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

STAAR Surgical has a beta of 1.26, suggesting that its stock price is 26% more volatile than the broader market. Comparatively, Senseonics Holdings, Inc. Common Stock has a beta of 1.01, suggesting that its stock price is 1% more volatile than the broader market.

Summary

STAAR Surgical beats Senseonics Holdings, Inc. Common Stock on 10 of the 17 factors compared between the two stocks.

How does Senseonics Holdings, Inc. Common Stock compare to PROCEPT BioRobotics?

PROCEPT BioRobotics (NASDAQ:PRCT) and Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings, media sentiment and valuation.

In the previous week, PROCEPT BioRobotics had 40 more articles in the media than Senseonics Holdings, Inc. Common Stock. MarketBeat recorded 44 mentions for PROCEPT BioRobotics and 4 mentions for Senseonics Holdings, Inc. Common Stock. Senseonics Holdings, Inc. Common Stock's average media sentiment score of 1.92 beat PROCEPT BioRobotics' score of 0.21 indicating that Senseonics Holdings, Inc. Common Stock is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PROCEPT BioRobotics
8 Very Positive mention(s)
4 Positive mention(s)
31 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Senseonics Holdings, Inc. Common Stock
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

PROCEPT BioRobotics has a beta of 0.89, suggesting that its share price is 11% less volatile than the broader market. Comparatively, Senseonics Holdings, Inc. Common Stock has a beta of 1.01, suggesting that its share price is 1% more volatile than the broader market.

Senseonics Holdings, Inc. Common Stock has lower revenue, but higher earnings than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than Senseonics Holdings, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PROCEPT BioRobotics$308.05M3.92-$95.57M-$1.94N/A
Senseonics Holdings, Inc. Common Stock$35.26M11.07-$69.11M-$2.23N/A

89.5% of PROCEPT BioRobotics shares are owned by institutional investors. Comparatively, 12.4% of Senseonics Holdings, Inc. Common Stock shares are owned by institutional investors. 4.0% of PROCEPT BioRobotics shares are owned by insiders. Comparatively, 4.7% of Senseonics Holdings, Inc. Common Stock shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

PROCEPT BioRobotics currently has a consensus price target of $28.00, indicating a potential upside of 32.89%. Senseonics Holdings, Inc. Common Stock has a consensus price target of $17.20, indicating a potential upside of 84.15%. Given Senseonics Holdings, Inc. Common Stock's stronger consensus rating and higher possible upside, analysts clearly believe Senseonics Holdings, Inc. Common Stock is more favorable than PROCEPT BioRobotics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PROCEPT BioRobotics
2 Sell rating(s)
10 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.19
Senseonics Holdings, Inc. Common Stock
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

PROCEPT BioRobotics has a net margin of -32.53% compared to Senseonics Holdings, Inc. Common Stock's net margin of -225.09%. PROCEPT BioRobotics' return on equity of -30.62% beat Senseonics Holdings, Inc. Common Stock's return on equity.

Company Net Margins Return on Equity Return on Assets
PROCEPT BioRobotics-32.53% -30.62% -22.10%
Senseonics Holdings, Inc. Common Stock -225.09%-165.80%-80.14%

Summary

Senseonics Holdings, Inc. Common Stock beats PROCEPT BioRobotics on 9 of the 17 factors compared between the two stocks.

Get Senseonics Holdings, Inc. Common Stock News Delivered to You Automatically

Sign up to receive the latest news and ratings for SENS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SENS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SENS vs. The Competition

MetricSenseonics Holdings, Inc. Common StockHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$397.96M$5.94B$7.40B$12.81B
Dividend YieldN/A1.75%2.53%11.02%
P/E Ratio-4.1925.89272.1924.12
Price / Sales11.0769.39631.9295.39
Price / CashN/A33.2179.8953.65
Price / Book4.326.2413.146.20
Net Income-$69.11M$149.10M$3.47B$348.07M
7 Day Performance2.52%0.53%1.38%0.67%
1 Month Performance92.18%9.26%8.62%4.84%
1 Year PerformanceN/A6.82%25.90%16.83%

Senseonics Holdings, Inc. Common Stock Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SENS
Senseonics Holdings, Inc. Common Stock
3.9997 of 5 stars
$9.34
-1.9%
$17.20
+84.2%
N/A$397.96M$35.26MN/A90
AORT
Artivion
3.9561 of 5 stars
$28.90
0.0%
$44.83
+55.1%
-39.5%$1.41B$441.33MN/A1,800
IART
Integra LifeSciences
1.9156 of 5 stars
$17.24
-1.8%
$18.86
+9.4%
+17.7%$1.36B$1.64BN/A4,427
DRTS
Alpha Tau Medical
1.6447 of 5 stars
$14.47
+1.5%
$12.80
-11.5%
+357.9%$1.29BN/AN/A80
STAA
STAAR Surgical
3.7353 of 5 stars
$24.66
+0.1%
$28.40
+15.2%
-15.7%$1.24B$239.44M352.341,211

Related Companies and Tools


This page (NASDAQ:SENS) was last updated on 8/26/2026 by MarketBeat.com Staff.
From Our Partners